According to Orthofix Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.48132. At the end of 2022 the company had a P/S ratio of 0.8917.
Year | P/S ratio | Change |
---|---|---|
2022 | 0.8917 | -32.53% |
2021 | 1.32 | -35.34% |
2020 | 2.04 | 7.02% |
2019 | 1.91 | -11.28% |
2018 | 2.15 | -6.36% |
2017 | 2.30 | 46.06% |
2016 | 1.57 | -14.71% |
2015 | 1.85 | 33.12% |
2014 | 1.39 | 33.35% |
2013 | 1.04 | -33.12% |
2012 | 1.55 | 38.73% |
2011 | 1.12 | 22.99% |
2010 | 0.9109 | -6.26% |
2009 | 0.9717 | 92.61% |
2008 | 0.5045 | -74.96% |
2007 | 2.01 | -10.5% |
2006 | 2.25 | 10.42% |
2005 | 2.04 | -4.85% |
2004 | 2.14 | -40.53% |
2003 | 3.60 | 66.65% |
2002 | 2.16 | -26.12% |
2001 | 2.93 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Stryker Corporation SYK | 5.44 | 267.12% | ๐บ๐ธ USA |
![]() NuVasive NUVA | 1.58 | 6.64% | ๐บ๐ธ USA |
![]() Smith & Nephew
SNN | 2.84 | 92.03% | ๐ฌ๐ง UK |
![]() Globus Medical GMED | 5.03 | 239.60% | ๐บ๐ธ USA |